Drug Database
BU

butocin (butocin / Benin)

✓ Approved

Spofa · HPRT1 · 小分子

什么是 butocin?

butocin 是一种小分子,由Spofa研发。该药已获批,用于治疗相关适应症。

药物档案

商品名butocin, Benin
公司Spofa
药物类别小分子
分子靶点HPRT1
状态Approved

作用机制

分子靶点

butocin 作用于 1 个分子靶点:

HPRT1hypoxanthine phosphoribosyltransferase 1 (HGPRT, HPRT)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

butocin 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Neoplasms benign, malignant and unspecified (incl cysts and polyps)Neoplasm malignant✓ Approved

相关研究文献

PubMedFolia microbiologica1995-01-01

Mutagenicity of cytostatic drugs in a bacterial system. I. Ames test.

Marhan J J

A set of nine cytostatic drugs were tested in the standard plate incorporation method of Ames reversion test using four Salmonella typhimurium his strains. Six of them were classical and commonly used cytostatics, three (cloturin, butocin and oracin) are at different stages of development. The results showed 6-mercaptopurine, cloturin, adriamycin, mitoxantron, cyclophosphamide and lomustine to be mutagenic; butocin, oracin and tris(2-chloroethyl)amine were negative in this test.

PMID 8763144
阅读全文 →
PubMedFolia microbiologica1995-01-01

Mutagenicity of cytostatic drugs in a bacterial system. II. DNA-repair test.

Marhan J J

A liquid micromethod modification of the DNA-repair test using an automatic growth analyzer was developed. The wild strain Escherichia coli WP2 and six repair-deficient isogenic test strains were used. To compare this repair test with the conventional plate Ames test, a set of nine cytostatics were tested. Cloturin, adriamycin, mitoxantron, oracin, lomustine and tris(2-chloroethyl)amine were found to be positive, and 6-mercaptopurine, butocin and cyclophosphamide negative. The experimental micromethod appears to be useful for assessing the differential lethality in bacteria and can be combined in any short-term test system to predict genotoxicity.

PMID 8763145
阅读全文 →
PubMedCeskoslovenska farmacie1985-07-01

[Determination of the tolerance and pharmacokinetics of butocin in persons with progressive polyarthritis].

Buchar E E, Perlík F F, Novotná P P, Janků I I

PMID 3896530
阅读全文 →
PubMedArzneimittel-Forschung1979-01-01

[Binding of butocin to serum proteins (author's transl)].

Grafnetterová J J, Kalousek I I, Vodrázka Z Z, Smahel O O

The binding of N-[-5-(6-purinylthio)-valeryl]-glycin ethylester (butocin, PVG) to serum proteins and pure human albumin was studied using the method of equilibrium dialysis. Its binding to protein in sera diluted 1:1 of 10 patients with malignant disease averaged 48.4 +/- 7.07%. At the butocin concentration of 20 micrograms/ml an average of 36% of butocin were bound to pure albumin. Only a small portion was bound to globulin fractions. Measurements of the saturation curve showed butocin to be bound to albumin molecule by one binding centre with a microscopic association constant kappa = 1.7 . 10(3) mol/l.

PMID 582741
阅读全文 →
PubMedNeoplasma1978-01-01

Dominant-lethal assay of selected cytostatics.

Sýkora I I, Gandalovicová D D

Dominant-lethal assays in male mice were made with the following cytostatics: Cyclophosphamide, TS-160, Edikron, Penberol, Cytembena, Mercaptopurine, Butocin, and Damvar. The cytostatics were administered mostly for 14-day periods, with the exception of Butocin (7 days) and high doses of Cyclophosphamide and TS-160 (single administrations). From the first day of administration on, the males were mated with intact females mostly at eight one-week intervals, and the quality of pregnancy was checked. Antifertility effects were found with TS 160, Penberol (at high dosage), and Mercaptopurine. Effects on permiogenesis with genetic risk were found with Cyclophosphamide, TS-160, Mercaptopurine, and less marked ones also with Cytembena. The effects were mostly manifested by increases in the numbers of early fetal resorptions, and less frequently by preimplantation loss of ova. No genetic risk was revealed by the assay in the cytostatics Edikron, Penberol, Butocin, and Damvar.

PMID 581697
阅读全文 →
PubMedSbornik lekarsky1976-08-01

[Clinical experience with butocin in the treatment of malignant tumours of the female genitalia (author's transl)].

Dvorák O O, Slavík V V

PMID 981950
阅读全文 →

注册免费账户还可查看另外 6 篇文献

免费注册查看全部文献 →

了解更多butocin